Latest filing published 14 Jun 2024 for Pasithea Therapeutics Corp., €14k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +70.3%Entry US$49.33 · Close at T+365 US$84.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alfred J. Novak: trading record in brief
Alfred J. Novak is a declared insider at 4 companies (board member); the most frequent names are LivaNova PLC, Cyberonics Inc and Dova Pharmaceuticals Inc. In total, 43 filings cover trades dated from 12 March 2007 to 13 June 2024.
On the open market, the record shows 1 purchase worth €41k and 14 sales worth €1.7M. Sales outweigh purchases by €1.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 18 share grants and 7 option exercises.
The record was last updated on 14 June 2024 with a share grant (€14k) in Pasithea Therapeutics Corp. The clock since the last published purchase (16 June 2020) now reads 2,336 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Alfred J. Novak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,750 shares@ US$5.6278.7% of flowCommon StockSEC:0001213900-24-053005:1
- 750 shares@ US$5.61100.0% of flowCommon StockSEC:0001213900-24-053005:0
- 97 shares@ US$59.940.5% of flowOrdinary SharesSEC:0001639691-22-000067:1
- 1,346 shares0Ordinary SharesSEC:0001639691-22-000067:0
- 2,337 shares@ US$89.1715.2% of flowOrdinary SharesSEC:0001639691-21-000113:1
- 644 shares@ US$90.7659100.0% of flowOrdinary SharesSEC:0001639691-21-000113:0
- 2,337 shares0Ordinary SharesSEC:0001639691-21-000076:0
- 58 shares@ US$48.292.0% of flowOrdinary SharesSEC:0001639691-20-000115:0
- 675 shares@ US$48.2923.6% of flowOrdinary SharesSEC:0001639691-20-000073:1
- 1,500 shares0Ordinary SharesSEC:0001639691-20-000073:0
- 1,000 shares@ US$46.7133.6% of flowOrdinary SharesSEC:0001639691-20-000068:0Canonical exit: 14 Sept 2020 (T+90)
- 6,901 sharesCommon StockSEC:0001209191-19-056042:0
- 1,048 shares0Ordinary SharesSEC:0001639691-19-000087:0
- 472 shares@ US$71.937.3% of flowOrdinary SharesSEC:0001639691-19-000087:1
- 1,300 shares@ US$70.6316.3% of flowOrdinary SharesSEC:0001639691-19-000078:0
- 6,901 sharesCommon StockSEC:0001209191-19-008112:0
- 771 shares@ US$94.4512.7% of flowOrdinary SharesSEC:0001639691-18-000120:1
- 1,715 shares0Ordinary SharesSEC:0001639691-18-000120:0
- 500 shares@ US$97.168.5% of flowOrdinary SharesSEC:0001639691-18-000117:0
- 1,000 shares@ US$104.4311.6% of flowOrdinary SharesSEC:0001639691-18-000067:0
- 1,000 shares@ US$84.027.0% of flowOrdinary SharesSEC:0001639691-18-000047:0
- 2,000 shares@ US$85.7714.5% of flowCommon StockSEC:0001639691-17-000100:0
- 1,497 shares@ US$60.417.5% of flowCommon StockSEC:0001639691-17-000075:1
- 3,327 shares0Common StockSEC:0001639691-17-000075:0
- 1,000 shares@ US$58.495.2% of flowCommon StockSEC:0001639691-17-000053:0
25 of 42 declarations
